Irene Litvan
Litvan, Irene.
VIAF ID: 59255941 (Personal)
Permalink: http://viaf.org/viaf/59255941
Preferred Forms
- 100 0 _ ‡a Irene Litvan
- 200 _ | ‡a Litvan ‡b Irene
-
-
-
-
- 100 1 _ ‡a Litvan, Irene
- 100 1 _ ‡a Litvan, Irene
- 100 1 _ ‡a Litvan, Irene
- 100 1 _ ‡a Litvan, Irene
-
- 100 1 _ ‡a Litvan, Irene
-
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Atypical Parkinsonian disorders : clinical and research aspects | |
Corticobasal degeneration and related disorders | |
Dementias, 2008: | |
Kobieta z zaburzeniami chodu i trudnościami w czytaniu | |
The pill questionnaire in a nondemented Parkinson's disease population. | |
Primary health care providers' knowledge gaps on Parkinson's disease | |
Progression of brain atrophy in PSP and CBS over 6 months and 1 year | |
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders | |
Progressive supranuclear palsy, 1992: | |
Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson's Disease | |
Pupillary diameter assessment: need for a graded scale. | |
The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease | |
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? | |
Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease | |
Reliability of the NINDS Myotatic Reflex Scale | |
Replication of association between ELAVL4 and Parkinson disease: the GenePD study | |
Reply: Corticobasal syndrome with Alzheimer's disease pathology | |
Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials | |
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases | |
The role of dispositional mindfulness in a stress-health pathway among Parkinson's disease patients and caregiving partners | |
Scientific position paper of the Movement Disorder Society evaluation of surgery for Parkinson's disease | |
Selective deficits in Alzheimer and parkinsonian dementia: visuospatial function | |
Slowed information processing in multiple sclerosis. | |
"Softening of the brain." Preface | |
Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. | |
Swallowing disturbances in the corticobasal syndrome | |
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. | |
Technology in Parkinson's disease: Challenges and opportunities | |
Therapy and management of frontal lobe dementia patients. | |
Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. | |
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease | |
Transcriptional analysis of peripheral memory T cells reveals Parkinson's disease-specific gene signatures | |
Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype | |
Unilateral left cerebral deterioration documented by CT, MRI, and neuropsychological studies: A possible case of pick's disease | |
Unique white matter structural connectivity in early-stage drug-naive Parkinson disease | |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium | |
The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment. | |
Validation of the MDS clinical diagnostic criteria for Parkinson's disease | |
The virtual reality of Parkinson's disease freezing of gait: A systematic review | |
Visualizing cortical activation during mental calculation with functional MRI. | |
The Wearable Multimodal Monitoring System: A Platform to Study Falls and Near-Falls in the Real-World | |
What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? | |
What can preservation of autobiographic memory after muscarinic blockade tell us about the scopolamine model of dementia? | |
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study | |
White-matter changes correlate with cognitive functioning in Parkinson's disease | |
Woman with gait impairment and difficulty reading | |
Yes/no reversals as neurobehavioral sequela: a disorder of language, praxis, or inhibitory control? | |
α-synuclein genetic variability: A biomarker for dementia in Parkinson disease | |
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease |